|
1
|
Kazandjian D: Multiple myeloma
epidemiology and survival: A unique malignancy. Semin Oncol.
43:676–681. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kristinsson SY, Anderson WF and Landgren
O: Improved long-term survival in multiple myeloma up to the age of
80 years. Leukemia. 28:1346–1348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Landgren O and Iskander K: Modern multiple
myeloma therapy: Deep, sustained treatment response and good
clinical outcomes. J Intern Med. 281:365–382. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sonneveld P and Broijl A: Treatment of
relapsed and refractory multiple myeloma. Haematologica.
101:396–406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hagiya M, Francavilla A, Polimeno L, Ihara
I, Sakai H, Seki T, Shimonishi M, Porter KA and Starzl TE: Cloning
and sequence analysis of the rat augmenter of liver regeneration
(ALR) gene: Expression of biologically active recombinant ALR and
demonstration of tissue distribution. Proc Natl Acad Sci USA.
91:8142–8146. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu J, Xu WX, Zhan YQ, Cui XL, Cai WM, He
FC and Yang XM: Identification and characterization of a novel
isoform of hepatopoietin. World J Gastroenterol. 8:353–356. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hofhaus G, Lee JE, Tews I, Rosenberg B and
Lisowsky T: The N-terminal cysteine pair of yeast sulfhydryl
oxidase Erv1p is essential for in vivo activity and interacts with
the primary redox centre. Eur J Biochem. 270:1528–1535. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cheng J, Zhong YW, Liu Y, Dong J, Yang JZ
and Chen JM: Cloning and sequence analysis of human genomic DNA of
augmenter of liver regeneration. World J Gastroenterol. 6:275–277.
2000.PubMed/NCBI
|
|
9
|
Gandhi CR, Kuddus R, Subbotin VM, Prelich
J, Murase N, Rao AS, Nalesnik MA, Watkins SC, DeLeo A, Trucco M, et
al: A fresh look at augmenter of liver regeneration in rats.
Hepatology. 29:1435–1445. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fass D: The Erv family of sulfhydryl
oxidases. Biochim Biophys Acta. 1783:557–566. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jung YS, Kim SJ, Kwon DY, Jun DS and Kim
YC: Significance of alterations in the metabolomics of
sulfur-containing amino acids during liver regeneration. Biochimie.
95:1605–1610. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferecatu I, Gonçalves S, Golinelli-Cohen
MP, Clémancey M, Martelli A, Riquier S, Guittet E, Latour JM,
Puccio H, Drapier JC, et al: The diabetes drug target MitoNEET
governs a novel trafficking pathway to rebuild an Fe-S cluster into
cytosolic aconitase/iron regulatory protein 1. J Biol Chem.
289:28070–28086. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Todd LR, Damin MN, Gomathinayagam R, Horn
SR, Means AR and Sankar U: Growth factor erv1-like modulates Drp1
to preserve mitochondrial dynamics and function in mouse embryonic
stem cells. Mol Biol Cell. 21:1225–1236. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ibrahim S and Weiss TS: Augmenter of liver
regeneration: Essential for growth and beyond. Cytokine Growth
Factor Rev. 45:65–80. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zeng HQ, Luo Y, Lou SF, Liu Q, Zhang L and
Deng JC: Silencing of augmenter of liver regeneration inhibited
cell proliferation and triggered apoptosis in U266 human multiple
myeloma cells. Braz J Med Biol Res. 50:e61392017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim HY, Stojadinovic A and Izadjoo MJ:
Immunization, hybridoma generation, and selection for monoclonal
antibody production. Methods Mol Biol. 1131:33–45. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Anders S and Huber W: Differential
expression analysis for sequence count data. Genome Biol.
11:R1062010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering
C, et al: STRING v9.1: Protein-protein interaction networks, with
increased coverage and integration. Nucleic Acids Res.
41D:D808–D815. 2013.
|
|
19
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: cytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vodovotz Y, Prelich J, Lagoa C, Barclay D,
Zamora R, Murase N and Gandhi CR: Augmenter of liver regeneration
(ALR) is a novel biomarker of hepatocellular stress/inflammation:
In vitro, in vivo and in silico studies. Mol Med. 18:1421–1429.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cao Y, Fu YL, Yu M, Yue PB, Ge CH, Xu WX,
Zhan YQ, Li CY, Li W and Wang XH: Human augmenter of liver
regeneration is important for hepatoma cell viability and
resistance to radiation-induced oxidative stress. Free Radic Biol
Med. 47:1057–1066. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45D:D353–D361. 2017.
View Article : Google Scholar
|
|
24
|
Sun Y, Liu WZ, Liu T, Feng X, Yang N and
Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation,
differentiation, migration, senescence and apoptosis. J Recept
Signal Transduct Res. 35:600–604. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Giorda R, Hagiya M, Seki T, Shimonishi M,
Sakai H, Michaelson J, Francavilla A, Starzl TE and Trucco M:
Analysis of the structure and expression of the augmenter of liver
regeneration (ALR) gene. Mol Med. 2:97–108. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu HY, Xiang DR, Huang HJ, Li J and Sheng
JF: Expression level of augmenter of liver regeneration in patients
with hepatic failure and hepatocellular carcinoma. Hepatobiliary
Pancreat Dis Int. 9:492–498. 2010.PubMed/NCBI
|
|
27
|
Gatzidou E, Mantzourani M, Giaginis C,
Giagini A, Patsouris E, Kouraklis G and Theocharis S: Augmenter of
liver regeneration gene expression in human colon cancer cell lines
and clinical tissue samples. J BUON. 20:84–91. 2015.PubMed/NCBI
|
|
28
|
Shen Y, Liu Q, Sun H, Li X, Wang N and Guo
H: Protective effect of augmenter of liver regeneration on
vincristine-induced cell death in Jurkat T leukemia cells. Int
Immunopharmacol. 17:162–167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Polimeno L, Pesetti B, Lisowsky T, Iannone
F, Resta L, Giorgio F, Mallamaci R, Buttiglione M, Santovito D,
Vitiello F, et al: Protective effect of augmenter of liver
regeneration on hydrogen peroxide-induced apoptosis in SH-SY5Y
human neuroblastoma cells. Free Radic Res. 43:865–875. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Polimeno L, Pesetti B, De Santis F, Resta
L, Rossi R, De Palma A, Girardi B, Amoruso A and Francavilla A:
Decreased expression of the augmenter of liver regeneration results
in increased apoptosis and oxidative damage in human-derived glioma
cells. Cell Death Dis. 3:e2892012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang LM, Liu DW, Liu JB, Zhang XL, Wang
XB, Tang LM and Wang LQ: Effect of naked eukaryotic expression
plasmid encoding rat augmenter of liver regeneration on acute
hepatic injury and hepatic failure in rats. World J Gastroenterol.
11:3680–3685. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ilowski M, Kleespies A, de Toni EN,
Donabauer B, Jauch KW, Hengstler JG and Thasler WE: Augmenter of
liver regeneration (ALR) protects human hepatocytes against
apoptosis. Biochem Biophys Res Commun. 404:148–152. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dayoub R, Thasler WE, Bosserhoff AK,
Singer T, Jauch KW, Schlitt HJ and Weiss TS: Regulation of
polyamine synthesis in human hepatocytes by hepatotrophic factor
augmenter of liver regeneration. Biochem Biophys Res Commun.
345:181–187. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Polimeno L, Pesetti B, Annoscia E, Giorgio
F, Francavilla R, Lisowsky T, Gentile A, Rossi R, Bucci A and
Francavilla A: Alrp, a survival factor that controls the apoptotic
process of regenerating liver after partial hepatectomy in rats.
Free Radic Res. 45:534–549. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liao XH, Zhang L, Liu Q, Sun H, Peng CM
and Guo H: Augmenter of liver regeneration protects kidneys from
ischaemia/reperfusion injury in rats. Nephrol Dial Transplant.
25:2921–2929. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liao XH, Chen GT, Li Y, Zhang L, Liu Q,
Sun H and Guo H: Augmenter of liver regeneration attenuates tubular
cell apoptosis in acute kidney injury in rats: The possible
mechanisms. Ren Fail. 34:590–599. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang N, Sun H, Shen Y, Li XF, Pan T, Liu
GL and Liu Q: Augmenter of liver regeneration inhibits apoptosis of
activated human peripheral blood lymphocytes in vitro.
Immunopharmacol Immunotoxicol. 35:257–263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Francavilla A, Vujanovic NL, Polimeno L,
Azzarone A, Iacobellis A, Deleo A, Hagiya M, Whiteside TL and
Starzl TE: The in vivo effect of hepatotrophic factors augmenter of
liver regeneration, hepatocyte growth factor, and insulin-like
growth factor-II on liver natural killer cell functions.
Hepatology. 25:411–415. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Weiss TS, Lupke M, Ibrahim S, Buechler C,
Lorenz J, Ruemmele P, Hofmann U, Melter M and Dayoub R: Attenuated
lipotoxicity and apoptosis is linked to exogenous and endogenous
augmenter of liver regeneration by different pathways. Plos One.
12:e01842822017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang TC, Chiu PR, Chang WT, Hsieh BS,
Huang YC, Cheng HL, Huang LW, Hu YC and Chang KL: Epirubicin
induces apoptosis in osteoblasts through death-receptor and
mitochondrial pathways. Apoptosis. 23:226–236. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Y, Li M, Xing G, Hu Z, Wang Q, Dong C,
Wei H, Fan G, Chen J, Yang X, et al: Stimulation of the
mitogen-activated protein kinase cascade and tyrosine
phosphorylation of the epidermal growth factor receptor by
hepatopoietin. J Biol Chem. 275:37443–37447. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhu J, Bing C and Wilding JPH:
1α,25(OH)2D3 attenuates IL-6 and IL-1β-mediated inflammatory
responses in macrophage conditioned medium-stimulated human white
preadipocytes by modulating p44/42 MAPK and NF-κB signaling
pathways. Diabetol Metab Syndr. 11:92019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yu Y, Wei SG, Zhang ZH, Weiss RM and
Felder RB: ERK1/2 MAPK signaling in hypothalamic paraventricular
nucleus contributes to sympathetic excitation in rats with heart
failure after myocardial infarction. Am J Physiol Heart Circ
Physiol. 310:H732–H739. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
von Kriegsheim A, Baiocchi D, Birtwistle
M, Sumpton D, Bienvenut W, Morrice N, Yamada K, Lamond A, Kalna G,
Orton R, et al: Cell fate decisions are specified by the dynamic
ERK interactome. Nat Cell Biol. 11:1458–1464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Sławińska-Brych A, Zdzisińska B, Czerwonka
A, Mizerska-Kowalska M, Dmoszyńska-Graniczka M, Stepulak A and
Gagoś M: Xanthohumol exhibits anti-myeloma activity in vitro
through inhibition of cell proliferation, induction of apoptosis
via the ERK and JNK-dependent mechanism, and suppression of sIL-6R
and VEGF production. Biochim Biophys Acta, Gen Subj.
1863:1294082019. View Article : Google Scholar
|
|
46
|
Park S, Lee HJ, Jeong SJ, Song HS, Kim M,
Lee HJ, Lee EO, Kim DH, Ahn KS and Kim SH: Inhibition of JAK1/STAT3
signaling mediates compound K-induced apoptosis in human multiple
myeloma U266 cells. Food Chem Toxicol. 49:1367–1372. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Dayoub R, Buerger L, Ibrahim S, Melter M
and Weiss TS: Augmenter of liver regeneration (ALR) exhibits a dual
signaling impact on hepatic acute-phase response. Exp Mol Pathol.
102:428–433. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Teng EC, Todd LR, Ribar TJ, Lento W,
Dimascio L, Means AR and Sankar U: Gfer inhibits Jab1-mediated
degradation of p27kip1 to restrict proliferation of hematopoietic
stem cells. Mol Biol Cell. 22:1312–1320. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yang J, Chen L, Yan Y, Qiu J, Chen J, Song
J, Rao Q, Ben-David Y, Li Y and Hao X: BW18, a C-21 steroidal
glycoside, exerts an excellent anti-leukemia activity through
inducing S phase cell cycle arrest and apoptosis via MAPK pathway
in K562 cells. Biomed Pharmacother. 112:1086032019. View Article : Google Scholar : PubMed/NCBI
|
